Expression and significance of tumor drug resistance related proteins and β-catenin in esophageal squamous cell carcinoma

Chinese Journal of Cancer

Volumn 29, Issue 3, 2010, Pages 300-305

  Gan, Si Yuan ^a   Zhong, Xue Yun ^a   Xie, Si Ming ^a   Li, Su Mei ^a   Peng, Hui ^b   Luo, Feng ^a  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^b GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

Author keywords

Bcl 2; Esophageal neoplasm; Image analysis; Immunohistochemistry; MRP2; P gp; Squamous cell carcinoma; Tissue microarray; catenin

Indexed keywords

ANTINEOPLASTIC AGENT; BETA CATENIN; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 2; PROTEIN BCL 2;

ADULT; AGED; ARTICLE; BASAL CELL; CARCINOGENESIS; CELL HYPERPLASIA; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; OPTICAL DENSITY; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 79951681549     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.009.10599     Document Type: Article

References (11)

1. Lo YL, Ho CT, Tsai FL. Inhibit multidrug resistance and induce apoptosis by using glycocholic acid and epirubicin [J]. Eur J Pharm Sci, 2008, 35 (1-2):52-67.
2. Szakacs G, Paterson JK, Ludwig JA, et al. Targeting multidrug resistance in cancer [J]. Nat Rev Drug Discov, 2006, 5(3):219-234.
3. Yamada T, Takaoka AS, Naishiro Y, et al. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/β-catenin complex in early colorectal carcinogenesis [J]. Cancer Res, 2000, 60(17):4761-4766.
4. Yan S, Zhou C, Zhang W, et al. β-catenin/TCF pathway upregulates STAT3 expression in human esophageal squamous cell carcinoma [J]. Cancer Lett, 2008, 271(1):85-97.
5. Mizushima T, Nakagawa H, Kamberov Y G, et al. Wnt-1 but not epidermal growth factor induces β-catenin/T-cell factor dependent transcription in esophageal cancer cells [J]. Cancer Res, 2002, 62(11): 277-282.
6. Peng H, Zhong XY, Liu KP, et al. Expression and significance of adenomatous polyposis coli, β-catenin, E-cadherin and cyclin D1 in esophageal squamous cell carcinoma assessed by tissue microarray [J]. Chin J Cancer, 2009, 28(1):49-53. [in Chinese]
7. Wang W, Liu HT, Chai YR, et al. Expression and significance of relevant factors of Wnt2, β-catenin, c-myc and cyclin D1 in esophageal squamous cell carcinoma tissue [J]. Zhong Liu Fang Zhi Yan Jiu, 2009, 36(3):213-215. [in Chinese]
8. Nelson WJ, Nusse R. Convergence of Wnt, β-catenin, and cadherin pathways [J]. Science, 2004, 303(5663):1483-1487.
9. Aloia TA, Harpole DH Jr, Reed CE, et al. Tumor marker expression is predictive of survival in patients with esophageal cancer [J]. Ann Thorac Surg, 2001, 72(3):859-866.
10. Han J, Tan BB, Geng W, et al. Correlation of expression of P-glycoprotein and inhibitor of apoptosis proteins to chemosensitivity in gastrointestinal carcinoma tissues [J]. Chin J Cancer, 2008, 27(11):1166-1171. [in Chinese]
11. Hong L, Piao Y, Han Y, et al. Zinc ribbon domain-containing 1 (ZNRD1) mediates multidrug resistance of leukemia cells through regulation of P-glycoprotein and Bcl-2 [J]. Mol Cancer Ther, 2005, 4(12):1936-1942.